difloxacin has been researched along with Dengue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arterburn, JB; Azar, SR; Chinnasamy, R; Gass, JT; Hanley, KA; Rossi, SL; Scroggs, SLP; Vasilakis, N; Widen, SG | 1 |
1 other study(ies) available for difloxacin and Dengue
| Article | Year |
|---|---|
Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness.
Topics: Adaptation, Biological; Animals; Antiviral Agents; Biological Evolution; Cell Line; Chlorocebus aethiops; Ciprofloxacin; Dengue; Dengue Virus; Drug Resistance, Viral; Enoxacin; Fluoroquinolones; Genetic Fitness; HEK293 Cells; Host Microbial Interactions; Humans; Mutation; Vero Cells; Viral Envelope; Virus Physiological Phenomena | 2021 |